propranolol has been researched along with Hypertriglyceridemia in 6 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of a one-month-old female patient with severe hypertriglyceridaemia as a side effect of treating an ulcerating infantile hemangioma with systemic propranolol." | 8.02 | Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma. ( Farshchian, M; Potts, GA, 2021) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 7.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| "We present a case of a one-month-old female patient with severe hypertriglyceridaemia as a side effect of treating an ulcerating infantile hemangioma with systemic propranolol." | 4.02 | Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma. ( Farshchian, M; Potts, GA, 2021) |
| " A diagnosis of autoimmune thyroiditis (AT) in thyrotoxic phase was made on the basis of clinical presentation and presence of anti-TPO antibodies and reduced uptake in thyroid (technetium) scintigraphy." | 3.91 | Auto-immune Thyroiditis in an Infant Masquerading as Congenital Nephrotic Syndrome. ( Bavdekar, SB; Jondhale, SN; Koppikar, RG; Save, SU, 2019) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 3.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| " In the light of the results obtained, the following conclusions were drawn: 1) hyperlipidemia affects pharmacodynamic properties of lipophilic propranolol and hydrophilic atenolol, 2) a modification of the drug dosage in hyperlipidemia is warranted." | 2.71 | [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol]. ( Droździk, M; Gawrońska-Szklarz, B; Sterna, R; Sulzyc-Bielicka, V; Telatyńska-Smieszek, B; Wójcicki, J, 2004) |
| "Propranolol was given orally as a single dose 80 mg." | 2.68 | [The effect of hypolipemic treatment on the pharmacokinetics of propranolol]. ( Sterna, R, 1997) |
| "Berardinelli- Seip syndrome is an autosomal recessive disorder characterized by generalized lipoatrophy, extreme insulin resistance with dyslipidemia in childhood and development of diabetes in adolescence." | 1.38 | An unusual cause of delayed puberty: Berardinelli- Seip syndrome. ( Dhull, P; Kumar, KV; Patnaik, SK; Upreti, V, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Farshchian, M | 1 |
| Potts, GA | 1 |
| Jondhale, SN | 1 |
| Save, SU | 1 |
| Koppikar, RG | 1 |
| Bavdekar, SB | 1 |
| Upreti, V | 1 |
| Dhull, P | 1 |
| Patnaik, SK | 1 |
| Kumar, KV | 1 |
| Telatyńska-Smieszek, B | 1 |
| Wójcicki, J | 1 |
| Droździk, M | 1 |
| Gawrońska-Szklarz, B | 1 |
| Sulzyc-Bielicka, V | 1 |
| Sterna, R | 2 |
| Witkowska, M | 1 |
| Lukasik, S | 1 |
| Kawecka, M | 1 |
| Moszczyńska, J | 1 |
| Karolko, B | 1 |
2 trials available for propranolol and Hypertriglyceridemia
| Article | Year |
|---|---|
[Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Area Under Curve; Atenolol; Blood Pressure; Chrom | 2004 |
[The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
Topics: Administration, Oral; Anticholesteremic Agents; Bezafibrate; Chromatography, High Pressure Liquid; D | 1997 |
4 other studies available for propranolol and Hypertriglyceridemia
| Article | Year |
|---|---|
Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
Topics: Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Hypertriglyceridemia; Infant; Propranolol; | 2021 |
Auto-immune Thyroiditis in an Infant Masquerading as Congenital Nephrotic Syndrome.
Topics: Carbimazole; Female; Hashimoto Disease; Humans; Hyperthyroidism; Hypertriglyceridemia; Hypoalbuminem | 2019 |
An unusual cause of delayed puberty: Berardinelli- Seip syndrome.
Topics: Administration, Cutaneous; Adolescent; Atorvastatin; Combined Modality Therapy; Diet, Fat-Restricted | 2012 |
[Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension].
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Hydrochlorothiazide; Hype | 1989 |